ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$JANX:NASDAQ · Janux Therapeutics Inc - US

Janux — masked T-cell engager oncology biotech

Sector: health

Conviction from: NASDAQCitrini

52-week range: 12.1235.34

2 tracked filer(s) hold this · 0 opened, 1 added, 1 trimmed in 30-JUN-2026

Aggregate 13FScore 72 — mean of 2 scored holder(s) · buyers (new/add) avg 80. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7280Added +72%1,993,837$30,625,3360.0%
Paul Tudor Jones / Tudor63Trimmed -5%28,070$431,1550.0%

Beyond 13F — activists, insiders, politicians & research

Citrini Research coverage report library →

ReportDateStance
#97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami2025-05-28LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-17.